Skip to Main Content

Author Details

Daniel H??bschmann
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
2016
56
23
PMIDPaper TitleJournal TitlePublished Year
37452721Levodopa-refractory hyperprolactinemia and pituitary findings in inherited disorders of biogenic amine metabolism.J Inherit Metab Dis2024
37452721Levodopa-refractory hyperprolactinemia and pituitary findings in inherited disorders of biogenic amine metabolism.J Inherit Metab Dis2024
36394265rGREAT: an R/bioconductor package for functional enrichment on genomic regions.Bioinformatics2023
35522148Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas.Haematologica2023
35680096simplifyEnrichment: A Bioconductor Package for Clustering and Visualizing Functional Enrichment Results.Genomics Proteomics Bioinformatics2023
36394265rGREAT: an R/bioconductor package for functional enrichment on genomic regions.Bioinformatics2023
37656784BRAF<sup>οβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability.Sci Adv2023
37734378Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity.Cell Rep Med2023
37884744NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology.NPJ Precis Oncol2023
37783805Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial.Nat Cancer2023
36888935National Center for Tumor Diseases Precision Oncology Thesaurus for Drugs: A Curated Database for Drugs, Drug Classes, and Drug Targets in Precision Cancer Medicine.JCO Clin Cancer Inform2023
36702933Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.Nat Cancer2023
36808802Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling.Mol Oncol2023
36789265aRgus: Multilevel visualization of non-synonymous single nucleotide variants &amp; advanced pathogenicity score modeling for genetic vulnerability assessment.Comput Struct Biotechnol J2023
36453648Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLs.Blood Adv2023
37656784BRAF<sup>οβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability.Sci Adv2023
37884744NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology.NPJ Precis Oncol2023
37783805Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial.Nat Cancer2023
37734378Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity.Cell Rep Med2023
35680096simplifyEnrichment: A Bioconductor Package for Clustering and Visualizing Functional Enrichment Results.Genomics Proteomics Bioinformatics2023
35522148Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas.Haematologica2023
36888935National Center for Tumor Diseases Precision Oncology Thesaurus for Drugs: A Curated Database for Drugs, Drug Classes, and Drug Targets in Precision Cancer Medicine.JCO Clin Cancer Inform2023
36789265aRgus: Multilevel visualization of non-synonymous single nucleotide variants &amp; advanced pathogenicity score modeling for genetic vulnerability assessment.Comput Struct Biotechnol J2023
36808802Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling.Mol Oncol2023
36702933Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.Nat Cancer2023
36453648Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLs.Blood Adv2023
34864868Make Interactive Complex Heatmaps in R.Bioinformatics2022
35763870Gene expression-based prediction of pazopanib efficacy in sarcoma.Eur J Cancer2022
35621918MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers.Mol Oncol2022
35801905Pkgndep: a tool for analyzing dependency heaviness of R packages.Bioinformatics2022
35681079Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).NPJ Precis Oncol2022
35983950Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinoma.Liver Int2022
35918329Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.Nat Commun2022
34864868Make Interactive Complex Heatmaps in R.Bioinformatics2022
35289356Improve consensus partitioning via a hierarchical procedure.Brief Bioinform2022
34849585spiralize: an R package for visualizing data on spirals.Bioinformatics2022
35801905Pkgndep: a tool for analyzing dependency heaviness of R packages.Bioinformatics2022
35763870Gene expression-based prediction of pazopanib efficacy in sarcoma.Eur J Cancer2022
35621918MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers.Mol Oncol2022
35681079Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).NPJ Precis Oncol2022
35983950Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinoma.Liver Int2022
35918329Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.Nat Commun2022
35289356Improve consensus partitioning via a hierarchical procedure.Brief Bioinform2022
34849585spiralize: an R package for visualizing data on spirals.Bioinformatics2022
33275159cola: an R/Bioconductor package for consensus partitioning through a general framework.Nucleic Acids Res2021
33953289Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.Leukemia2021
34049392Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model.Neuro Oncol2021
33833736Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.Front Endocrinol (Lausanne)2021
33341987Poly(ADP-ribose) polymerase inhibition in pancreatic cancer.Genes Chromosomes Cancer2021
33275159cola: an R/Bioconductor package for consensus partitioning through a general framework.Nucleic Acids Res2021
  • 1 - 50 of 112

Recommended Authors

Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Washington University
Career Start Year 2009
Number of shared co-authors 7
University of Lausanne (UNIL)
Career Start Year 2008
Number of shared co-authors 5
Brigham Young University
Career Start Year 2008
Number of shared co-authors 5
University of California los angeles
Career Start Year 2008
Number of shared co-authors 26
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 14
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 9
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 23
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 7
Center for Molecular Medicine, University Medical Center Utrecht
Career Start Year 2006
Number of shared co-authors 5
Department of Immunology Erasmus University Medical Center
Career Start Year 2006
Number of shared co-authors 4
Uniformed Services University of the Health Sciences
Career Start Year 2004
Number of shared co-authors 7
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 15
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 9
Washington University
Career Start Year 2003
Number of shared co-authors 9
University of California
Career Start Year 2003
Number of shared co-authors 2
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 7
Washington University
Career Start Year 2003
Number of shared co-authors 9
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 10
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 53
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 3
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 4
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 0
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 32
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Career Start Year 1997
Number of shared co-authors 1
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 18
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 24
University of California San Diego
Career Start Year 1992
Number of shared co-authors 22
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 0

Collaborators

University of Augsburg
Co-authored papers 26
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 22
Berlin Institute of Health (BIH) and Charite
Co-authored papers 20
German Cancer Research Center (DKFZ)
Co-authored papers 18
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 16
National Center for Tumor Diseases (NCT) Heidelberg
Co-authored papers 15
Co-authored papers 14
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers 12
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 10
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 10
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers 9
Co-authored papers 8
Co-authored papers 7
German Cancer Research Center (DKFZ)
Co-authored papers 7
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Co-authored papers 7
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 6
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 6
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 6
Co-authored papers 6
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 5
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Co-authored papers 5
University of California san francisco
Co-authored papers 5
Co-authored papers 5
German Cancer Research Center (DKFZ)
Co-authored papers 4
Co-authored papers 4
Heidelberg University
Co-authored papers 4
Co-authored papers 4
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 4
University of Copenhagen
Co-authored papers 4
German Cancer Research Center (DKFZ)
Co-authored papers 4